Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BioNTech SE
  6. News
  7. Summary
    BNTX   US09075V1026

BIONTECH SE

(BNTX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

HC Wainwright Upgrades BioNTech SE to Buy from Neutral

11/10/2021 | 01:50pm EST


© MT Newswires 2021
All news about BIONTECH SE
12:20pMorgan Stanley Adjusts BioNTech's Price Target to $284 from $294, Keeps Equalweight Rat..
MT
11:10aEuropean ADRs Move Lower in Tuesday Trading
MT
10:01aEuropean Medicines Agency Says mRNA COVID-19 Vaccines Safe In Pregnancy
MT
01/14Omicron leaves Germany on brink of recession as growth dips
AQ
01/14German economy short of pre-pandemic level despite 2.7% growth in 2021
RE
01/13European ADRs Move Higher in Thursday Trading
MT
01/13Acuitas Therapeutics Names Miranda Lam as
AQ
01/13Positive Top-Line Results of Pfizer's Phase 3 Study Exploring Coadministration of PREVN..
AQ
01/13WHO, EMA Warn Against Repeated COVID-19 Booster Shots
MT
01/12Pfizer's Pneumonia Jab, COVID-19 Booster Shot Safe for Coadministration in Late-Stage S..
MT
More news
Analyst Recommendations on BIONTECH SE
More recommendations
Financials
Sales 2021 17 454 M 19 815 M 19 815 M
Net income 2021 9 220 M 10 467 M 10 467 M
Net cash 2021 8 918 M 10 125 M 10 125 M
P/E ratio 2021 4,68x
Yield 2021 -
Capitalization 41 474 M 47 338 M 47 085 M
EV / Sales 2021 1,87x
EV / Sales 2022 1,41x
Nbr of Employees 2 800
Free-Float -
Chart BIONTECH SE
Duration : Period :
BioNTech SE Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIONTECH SE
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 16
Last Close Price 171,72 €
Average target price 263,77 €
Spread / Average Target 53,6%
EPS Revisions
Managers and Directors
Ugur Sahin Chief Executive Officer
Jens Holstein Chief Financial Officer
Helmut Jeggle Chairman-Supervisory Board
Özlem Türeci Chief Medical Officer
Sierk Pötting Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
BIONTECH SE-23.97%47 338
GILEAD SCIENCES, INC.-1.16%90 027
REGENERON PHARMACEUTICALS-2.58%64 327
VERTEX PHARMACEUTICALS6.58%59 510
WUXI APPTEC CO., LTD.-3.73%52 665
BEIGENE, LTD.-11.92%24 519